

Health Care: Drugs
Biovail Corporation International (BVF: NYSE)
$26.35 -0.76 | -2.80%
09/27/10 - 04:01 PM ET
14.82M / 3.29M
Vol / Avg. Vol:
27.22 / 27.11
Open / Prev. Close:
26.30 - 27.53
Today's Range:
12.91 - 27.74
52 Wk Range:
Partner Headlines for BVF
- Biovail Backpedals From Allegations, Again - Seeking Alpha 11.07.10 | 08:11 am
- Thursday Options Update: AMAG, BID, ERIC, BAX, NVDA, VIT, BVF, ETFC - Seeking Alpha 09.24.10 | 03:09 pm
- Thursday Options Brief: NVDA, VIT, BVF, ETFC - Seeking Alpha 09.24.10 | 01:09 pm
- Valeant Pharmaceuticals Rallying On Job Cuts (VRX) - Benzinga 09.07.10 | 09:09 am
- Biovail Rallying On UBS Target Increase (BVF) - Benzinga 09.07.10 | 09:09 am
- WRAPUP 3-Biovail, Paladin profits beat estimates - Reuters 08.05.10 | 05:08 pm
- Jefferies Places Valeant Pharma on Their Restricted List (VRX) - Benzinga 08.04.10 | 09:08 am
- Piper Jaffray Upgrades Biovail to Overweight (BVF) - Benzinga 07.16.10 | 09:07 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 07.16.10 | 09:07 am
- Biovail Corp. (BVF) bearishness crosses tape due to buying - ONN.TV 07.02.10 | 05:07 pm